---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-011124"
form_type: "8-K"
ticker: "GMED"
cik: "0001237831"
company_name: "GLOBUS MEDICAL INC"
filed_at: "2026-02-24T23:59:59+00:00"
generated_at: "2026-05-16T00:42:08.814228+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Globus Medical Q4 revenue $826.4M (+25.7% YoY); EPS $1.03 GAAP / $1.28 non-GAAP

## Summary
- Q4 worldwide net sales $826.4M, up 25.7% YoY; base business ex-Nevro up 10.6%.
- GAAP diluted EPS $1.03 (vs $0.19); non-GAAP diluted EPS $1.28 (vs $0.84), up 52.1%.
- Full year 2025 revenue $2,938.9M (+16.7%); GAAP EPS $3.92; non-GAAP EPS $3.98.
- 2026 guidance: revenue $3.18-3.22B; non-GAAP EPS raised to $4.40-4.50 from $4.30-4.40.
- US Spine revenue grew 10% in Q4; Enabling Technologies grew 19% over prior-year quarter.

## SEC filing metadata
- accession: 0001628280-26-011124
- form_type: 8-K
- ticker: GMED
- cik: 0001237831
- company_name: GLOBUS MEDICAL INC
- filed_at: 2026-02-24T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011124/0001628280-26-011124-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1237831/000162828026011124/gmed-20260224.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-011124
- JSON: https://secwatch.observer/filing/0001628280-26-011124.json
- Plain text: https://secwatch.observer/filing/0001628280-26-011124.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.